MAXON/PIXOLOGIC
11.1.2022 19:42:13 CET | Business Wire | Press release
Maxon, developer of professional 3D software solutions, is pleased to announce the completion of all financial and regulatory requirements for the acquisition of all assets of Pixologic, creators of the Academy Award-winning ZBrush sculpting and painting software. As an added benefit, the entire ZBrush team has already joined Maxon, bringing decades of 3D industry expertise. The move suitably rounds out Maxon’s product line and firmly positions the company as an industry leader for providing superior creative tools to digital artists to the €16 billion 3D Animation Industry.*
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110006049/en/
No interruptions are expected for the ongoing development of ZBrush post-acquisition. Nevertheless, the collaboration with Maxon’s development team, access to its other technologies and the potential integrations therein are expected to bring greater innovation and expanded capabilities to ZBrush and the entire Maxon product line. Additionally, the inclusion of the ZBrush team assures greater marketing, training and support resources.
“We are excited to start working with the Maxon team,” said Ofer Alon, Founder and Visionary of Pixologic. “Our synergies are undeniable - both companies share a great tradition of outstanding products, innovation and a passion to serve the creative community.”
“I’m excited to see how this alliance will influence, evolve and enrich all our product offerings,” stated David McGavran, Maxon CEO. “We have our eyes towards not only transforming creative workflows; we’re aspiring to revolutionize the industry.”
Immediate Impact: Pricing and Availability
Until further notice, ZBrush pricing remains unchanged following the completion of the acquisition. Customers can continue to purchase ZBrush through their usual sales channels, including the ZBrush online store.
Please refer to the FAQ for additional information.
*Research and Markets, Global 3D Animation Market Size, Share & Trends Analysis Report by Technique (3D Modeling, Visual Effects), by Component, by Deployment (On-premise, On-demand), by End Use, and Segment Forecasts, 2021-2028, June 2021 - More Info
About ZBrush
ZBrush is used by respected film studios, game developers, designers, advertisers, illustrators, and scientists around the world. The industry’s top creatives have employed ZBrush for nearly every major franchise including Dune, Star Wars, Avatar, the Marvel Cinematic Universe, Game of Thrones, Lord of the Rings/The Hobbit and more. Its versatility has also made it an integral part of animated features such as Frozen, Moana, Raya and the Last Dragon, and Encanto. ZBrush has also been used extensively in Triple A games including Fortnite, the God of War franchise, Uncharted franchise, Assassin's Creed franchise, Far Cry franchise
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110006049/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Reports Third Quarter 2026 Results3.11.2026 22:30:00 CET | Press release
Delivered Strong Sales, Profit and Cash Flow Performance in Third Quarter 2026Raising Low-End of Full Year 2026 Financial Guidance RangesRecently Completed $500M Share Repurchase AuthorizationFood Ingredients Divestiture Progressing Well and On Track to Close by End of Second Quarter 2027 IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Management Commentary “IFF delivered a solid third quarter, with improved sales and profitability across all divisions,” said Erik Fyrwald, CEO of IFF. “Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modes
2026–2027 World Branding Awards Honours Global “Brand of the Year” Winners at Hampton Court Palace3.11.2026 21:00:00 CET | Press release
The World Branding Awards returned to honour the brands that continue to set the benchmark for excellence. The 2026–2027 World Branding Awards Ceremony took place at the iconic Hampton Court Palace, marking the 21st edition of the awards. Set within the grandeur of a historic venue, the prestigious event brought together guests from across the globe for a memorable celebration. The evening was hosted by the acclaimed BBC presenter, Hannah Gray, and was further enriched by a keynote presentation from renowned speaker Adrian Webster. Earning a World Branding Awards remains a highly distinguished achievement. Winners are determined through a rigorous evaluation process encompassing brand valuation, consumer market research, and public online voting. This year, over 105,000 consumers took part in the voting process, and more than 2,000 brands from 62 countries were nominated. Of these, less than 10 brands from each country were declared the “Brand of the Year” across the Global, Regional,
Gencom Acquires Rosewood London, Expanding Its Footprint With Its First Luxury Hotel Acquisition in Europe3.11.2026 19:05:00 CET | Press release
Located in one of the world’s most prestigious hospitality corridors, the acquisition of the 308-key hotel represents a major milestone in the firm’s international growth. Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London, the landmark 308-key luxury hotel situated at 252 High Holborn in Central London. The acquisition strengthens Gencom’s global hospitality investment platform and expands its presence in Europe through its first luxury hotel asset in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103137897/en/ Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London in Central London London is one of the world’s most supply-constrained hospitality markets, supported by year-round demand from both leisure and business travelers. The acquisi
SGCA Honours Communication Excellence Across Asia, Europe and the Arab World3.11.2026 16:52:00 CET | Press release
His Highness Sheikh Dr Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, honoured winners of the 13th Sharjah Government Communication Award (SGCA), organised by the Sharjah Government Media Bureau (SGMB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103972039/en/ SGCA honours communication excellence across Asia, Europe and the Arab world (Photo: AETOSWire) Winners represented China, India, Thailand, Ukraine and the Arab world. Some 433 entries from 31 countries across four continents passed initial screening. The award covered 23 categories across five sectors, including six partner awards. His Excellency Tariq Saeed Allay, Director General of SGMB, highlighted the award’s growth under the vision of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, noting that it had attracted more than 9,500 entries over five year
BioLife to Showcase Oral Peptide Delivery Technology During London Life Sciences Week3.11.2026 16:03:00 CET | Press release
Company to highlight granted patent portfolio, preclinical semaglutide data and potential applications across future peptide medicines at LSX Investival BioLife Products Limited today announced its participation in London Life Sciences Week, where it will highlight its patented oral peptide delivery technology and recent advances in its intellectual property portfolio. BioLife will present at the LSX Investival Showcase on Monday, November 16, 2026, from 3:15 to 3:30 p.m. GMT, at Old Billingsgate, London. The presentation will be led by Former US Ambassador James P. Cain, Strategic Advisor to the Chairman & Founder, alongside Ludivine Delattre, Business and Corporate Relations, and will highlight the scientific journey behind the technology and its potential applications. BioLife is focused on developing a novel approach to delivering peptide therapeutics orally. Built on over 35 years of pharmaceutical effervescence expertise and two decades of oral peptide research by founder and inv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom